Abrysvo act-o-vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9GD1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,850
Award facts
- Contract value 100% obligated
- $39,849.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $39,849.60 delivery order to AmerisourceBergen Drug Corp for ACT-O-VIALS on December 17, 2025, with an ultimate completion date of December 18, 2025. This non-set-aside contract employs firm fixed-price pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs.
AmerisourceBergen Drug Corp holds a comprehensive IDC valued at $999,999,999.00 through December 2026 that serves as a global pharmaceutical support vehicle for military healthcare programs. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for ACT-O-VIALS represents one of numerous competitively awarded transactions through this prime vendor arrangement, reflecting AmerisourceBergen's established position as a critical supplier within the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9GD1?
SPE2DR26F9GD1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F9GD1 worth?
The government has obligated $39,850 on SPE2DR26F9GD1.
Is contract SPE2DR26F9GD1 an order under another contract?
Yes. SPE2DR26F9GD1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GD1 competed?
The extent of competition for SPE2DR26F9GD1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award